New England Journal of Medicine, May 7, 2007 (on-line version)
An op-ed appearing in the New England Journal of Medicine analyzes the data used by the FDA -- plus some it didn’t include -- to arrive at the recent decision to expandblack box warnings about antidepressants and the risk of suicide for people under the age of 24. “The new black-box warning is clearly an attempt to balance the small risk posed by antidepressants against their well-documented benefits. But this new label has the potential to confuse both patients and physicians.”
Consider This
by Phyllis Vine
MIWatch.org on Facebook
Relevant Sites
- Visit the Illinois neurology department of Northshore
Featured Videos
Most Popular
MIWatch Archives
This site complies with the HONcode standard for trustworthy health information:
verify here.
